Nav: Home

Different types of ovarian cancer have different causes

November 02, 2015

THE more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research* presented at the 2015 National Cancer Research Institute (NCRI) Cancer Conference today (Tuesday).

Data was collected from more than 8000 women with ovarian cancer as part of the UK Million Women Study.

Researchers then examined the risk of the four most common types of ovarian cancer - serous, mucinous, endometrioid and clear cell tumours - in women with different childbearing patterns.

For ovarian cancer overall, women with one child had about a 20 per cent reduction in risk compared to women without children, and about a 40 cent reduction of endometrioid and clear cell tumours.

Each additional birth then offered an estimated eight per cent reduction in the overall risk of ovarian cancer.

Researchers also compared risk between those women who had surgery to cut or clip their fallopian tubes with those who had not. This procedure - known as tubal ligation or sterilisation - is a surgical procedure for permanent contraception.

Women who had had this surgery had a 20 per cent lower overall risk of ovarian cancer. The risk was about 20 per cent lower for high-grade serous tumours - the most common type of ovarian cancer - and about halved for endometrioid and clear cell tumours.

Dr Kezia Gaitskell, Cancer Research UK funded lead researcher and pathologist based at the Cancer Epidemiology Unit, University of Oxford, said: "In the last few years, our understanding of ovarian cancer has been revolutionised by research showing that many cases may not in fact come from the ovaries. For example, many high-grade serous tumours - the most common type - seem to start in the fallopian tubes, while some endometrioid and clear cell tumours may develop from endometriosis.

"We think that the significant reduction in risk among women with one child compared to women without children is likely to be related to infertility, as there are some conditions - such as endometriosis - that may make it harder for a woman to become pregnant, and which may also increase her risk of these specific types of ovarian cancer.

"For the reduced risk seen among women with tubal ligation - it could be that tubal ligation acts as a barrier to help prevent the abnormal cells that might cause these tumours passing through the fallopian tubes to the ovaries. Our results are really interesting, because they show that the associations with known risk factors for ovarian cancer, such as childbirth and fertility, vary between the different tumour types."

Professor Charlie Swanton, Chair of the 2015 NCRI Cancer Conference, said: "We've known for some time that the number of children a woman has, and her use of contraception, can influence her risk of ovarian cancer, so this research provides important further detail about different types of the disease.

"Ovarian cancer - like many other cancers - is not one disease, but different diseases that are grouped together because of where they start. It's important to know what affects the risk of different types of ovarian cancer and what factors impact this. We now need to understand the mechanisms behind these findings to develop some way to extend this lower risk to all women, regardless of how many children they have."
-end-
For media enquiries contact the NCRI press office on 0151 707 4642/43/44/45/46 or, out of hours, on 07050 264 590.

Notes to editor:

http://abstracts.ncri.org.uk/abstract/childbearing-patterns-and-ovarian-cancer-in-the-million-women-study-variation-by-histological-subtype/

The researchers have made the following calculations for the absolute risk of ovarian cancer relating to how many children a woman has, or if she has had her fallopian tubes cut.


  • Around 7000 women are diagnosed with ovarian cancer every year in the UK - Based on the number of cases of ovarian cancer (ICD10 C56-C57.4) diagnosed in the UK in 2012

  • In the UK, the lifetime risk of developing ovarian cancer is 1 in 51 for women. Lifetime risk of being diagnosed with ovarian cancer (ICD10 C56-C57). Calculated by Cancer Research UK Stats Team using the AMP method. Based on 2010 data.
For the latest statistics on ovarian cancer visit http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer

Ovarian cancers are classified depending on the type of cells and where they start growing from. Epithelial ovarian cancer is the most common form of the disease, responsible for nine out of ten cases, and there are various sub-types of epithelial ovarian cancers - including serous, endometrioid, clear cell and mucinous tumours.

These results come from the Million Women Study, which is funded by Cancer Research UK and the Medical Research Council.

Tubal ligation is a surgical procedure for sterilisation in which a woman's fallopian tubes are clamped and blocked, or severed and sealed. The aim is to prevent eggs from reaching the uterus for implantation. Tubal ligation is considered a permanent method of sterilisation and birth control. It is also known as having your "tubes tied".

http://www.nhs.uk/conditions/contraception-guide/pages/female-sterilisation.aspx#female

Results of the work on tubal ligation are in press at the International Journal of Cancer: http://onlinelibrary.wiley.com/doi/10.1002/ijc.29856/abstract

About the NCRI

The National Cancer Research Institute (NCRI) was established in 2001. It is a UK-wide partnership between cancer research funders which promotes collaboration in the field. Its member organisations work together to maximise the value and benefits of cancer research for patients and the public.

NCRI members are: Biotechnology and Biological Sciences Research Council; Bloodwise (formerly Leukaemia& Lymphoma Research); Breast Cancer Now; Cancer Research UK; Children with Cancer UK, Department of Health; Economic and Social Research Council; Macmillan Cancer Support; Marie Curie; Medical Research Council; Northern Ireland Health and Social Care Public Health Agency (Research & Development Department); Prostate Cancer UK; Roy Castle Lung Cancer Foundation; Scottish Government Health Directorates (Chief Scientist Office); Tenovus Cancer Care; The Wellcome Trust; Welsh Assembly Government (Health and Care Research Wales); and Worldwide Cancer Research (formerly AICR).

For more information visit http://www.ncri.org.uk

About the NCRI Cancer Conference

The NCRI Cancer Conference is the UK's major forum for showcasing the best British and international cancer research.
  • The Conference offers unique opportunities for networking and sharing knowledge by bringing together world-leading experts from all cancer research disciplines.
  • The NCRI Cancer Conference is taking place from 1-4 November 2015 at the BT Convention Centre in Liverpool.
  • For more information visit conference.ncri.org.uk


Cancer Research UK

Related Ovarian Cancer Articles:

Uncovering the mechanisms that support the spread of ovarian cancer
In this issue of the JCI, research led by Wang Min at Yale University describes how a subtype of macrophages communicate with and support tumor cell growth to drive metastasis in ovarian cancer.
Ovarian cancer study uncovers new biology
In what is believed to be the largest study of its kind, scientists at The Johns Hopkins University and the Pacific Northwest National Laboratory led a study that examined the proteomes of 169 ovarian cancer patients to identify critical proteins expressed by their tumors.
Chemotherapy may boost immunotherapy power in ovarian cancer
Cancer Research UK scientists have found that women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy.
UA engineers zero in on early detection of ovarian cancer
University of Arizona researcher Jennifer Barton is leading a two-year, $1 million project funded by the National Cancer Institute to identify imaging biomarkers of ovarian cancer, the most deadly gynecological cancer in the United States.
Ludwig Cancer Research and CRI initiate clinical trial of immunotherapy for ovarian cancer
Ludwig Cancer Research and the Cancer Research Institute (CRI) have launched a Phase 1/2 clinical trial of combination immunotherapy for advanced ovarian cancer.
Different types of ovarian cancer have different causes
The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 National Cancer Research Institute Cancer Conference Tuesday.
Researchers isolate possible ovarian cancer biomarkers
Researchers from North Carolina State University utilized a highly sensitive mass spectrometry analysis to identify and measure difficult-to-detect N-glycan biomarkers associated with ovarian cancers in stages I-IV.
New Stand Up To Cancer-OCRF-OCNA-NOCC Ovarian Cancer Dream Team announced
The Stand Up To Cancer, Ovarian Cancer Research Fund, Ovarian Cancer National Alliance, and National Ovarian Cancer Coalition $6 milion Ovarian Cancer Dream Team will focus on DNA repair pathways and therapies for ovarian cancer, seeking to expand on the recent clinical advances seen with PARP inhibitors.
Seeking new targets for ovarian cancer treatment
Identifying molecular changes that occur in tissue after chemotherapy could be crucial in advancing treatments for ovarian cancer, according to research from Magee-Womens Research Institute and Foundation and the University of Pittsburgh Cancer Institute presented today at the American Association for Cancer Research Annual Meeting 2015.
'Patchwork' ovarian cancer more deadly
The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a Cancer Research UK study published today in PLOS Medicine.

Related Ovarian Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...